Back to Search
SARAH KAYE, PH.D.
PH.D.
Psychologist
NPI: 1679582779Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
7521(MA)
Research & Publications (20)
The promises and pitfalls of epigenetic therapies in solid tumours.
PMID 19211243·Eur J Cancer·2009
6-review
In silico mutation of cysteine residues in the ligand-binding domain of an N-methyl-D-aspartate receptor.
PMID 17269660·Biochemistry·2007
7-preclinical
New paradigms in the treatment of breast and colorectal cancer--an introduction.
PMID 11841928·Eur J Cancer·2002
8-other
Combination chemotherapy for ovarian cancer--lessons not yet learned?
PMID 11937008·Curr Oncol Rep·2002
8-other
Docetaxel in ovarian cancer: phase III perspectives and future development.
PMID 12170448·Semin Oncol·2002
6-review
The integration of docetaxel into first-line chemotherapy for ovarian cancer.
PMID 11489000·Int J Gynecol Cancer·2001
8-other
Intravenous chemotherapy for ovarian cancer - the state of the art?
PMID 11240728·Int J Gynecol Cancer·2000
8-other
Penetrating and deep anterior lamellar keratoplasty for keratoconus: a comparison of graft outcomes in the United kingdom.
PMID 19661238·Invest Ophthalmol Vis Sci·2009
4-observational
Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.
PMID 19470933·J Clin Oncol·2009
3-trial
Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
PMID 19604654·Drug Alcohol Depend·2009
4-observational
Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies.
PMID 19506565·Int J Obes (Lond)·2009
1-meta
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors.
PMID 19509256·Mol Cancer Ther·2009
3-trial
Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer.
PMID 19515553·Eur J Cancer·2009
3-trial
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.
PMID 19542250·Ann Oncol·2009
3-trial
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
PMID 19553641·N Engl J Med·2009
3-trial
Safety and efficacy of patupilone in patients with advanced ovarian, primary fallopian, or primary peritoneal cancer: a phase I, open-label, dose-escalation study.
PMID 19451434·J Clin Oncol·2009
3-trial
Observations of reduced electron Gyroscale fluctuations in national spherical torus experiment H-mode plasmas with large ExB flow shear.
PMID 19658873·Phys Rev Lett·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 813 WILLIAMS ST
LONGMEADOW, MA 01106 - Phone
- (413) 565-5005
Quick Facts
- NPI
- 1679582779
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile